Auris Medical (EARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EARS | FGEN | NERV | ||
| Company | Auris Medical | Fibrogen Inc CS | Minerva Neuroscie | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.08 | 8.77 | 3.79 | ||
| High | 3.09 | 9.09 | 4.17 | ||
| Low | 3.00 | 8.70 | 3.64 | ||
| Latest | 3.05 | 8.70 | 4.08 | ||
| Change | -0.06 | -0.12 | +0.17 | ||
| % Change | -1.77% | -1.36% | +4.35% | ||
| Volume | 174,000 | 12,100 | 57,700 | ||
| 20-Day Average Volume | 551,145 | 28,765 | 72,445 | ||
| Previous Close | 3.10 | 8.82 | 3.91 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.28 | 8.55 | 3.92 | ||
| 20-Day Raw Stochastic | 25.79% | 50.00% | 61.48% | ||
| 20-Day Relative Strength | 43.74 | 41.50 | 54.99 | ||
| Weighted Alpha | +3.04 | +5.85 | +27.94 | ||
| Today's Opinion | 24% Sell | 40% Sell | 96% Buy | ||
| Previous Opinion | 24% Sell | 40% Sell | 80% Buy | ||
| Last Month's Opinion | 80% Buy | 40% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.57% since 07/16/21 | +5.45% since 12/04/25 | +9.09% since 12/04/25 | ||
| Low | 2.80 on 07/19/21 | 8.23 on 12/05/25 | 3.51 on 12/09/25 | ||
| High | 3.35 on 07/22/21 | 9.09 on 12/11/25 | 4.17 on 12/11/25 | ||
| 1-Month | |||||
| %Chg | -13.25% since 06/23/21 | -12.47% since 11/11/25 | +2.77% since 11/11/25 | ||
| Low | 2.80 on 07/19/21 | 7.99 on 12/04/25 | 3.25 on 12/03/25 | ||
| High | 3.75 on 06/28/21 | 10.09 on 11/12/25 | 4.60 on 11/17/25 | ||
| 3-Month | |||||
| %Chg | -8.83% since 04/23/21 | -30.01% since 09/11/25 | +91.55% since 09/11/25 | ||
| Low | 2.78 on 05/06/21 | 7.99 on 12/04/25 | 1.93 on 09/18/25 | ||
| High | 4.58 on 06/03/21 | 12.58 on 09/25/25 | 12.46 on 10/21/25 | ||
| 6-Month | |||||
| %Chg | -7.16% since 01/22/21 | +12.62% since 06/11/25 | +135.84% since 06/11/25 | ||
| Low | 2.70 on 03/05/21 | 4.85 on 06/30/25 | 1.57 on 07/01/25 | ||
| High | 6.25 on 03/09/21 | 12.60 on 09/03/25 | 12.46 on 10/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 34,765 | 35,195 | 28,519 | ||
| Shares Outstanding, K | 11,417 | 4,045 | 6,990 | ||
| Annual Sales | 174,475 | 29,620,000 | 0 | ||
| Annual Net Income | -8,750,000 | -47,580,000 | 1,440,000 | ||
| Last Quarter Sales | 0 | 1,080,000 | 0 | ||
| Last Quarter Net Income | -3,690,866 | 200,640,000 | -2,740,000 | ||
| 60-Month Beta | 1.17 | 0.74 | -0.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.61 on 11/10/25 | -0.36 on 11/05/25 | ||
| Latest Earnings Date | 01/01/70 | 03/16/26 | 02/24/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||